Star Lake Bioscience Co., Inc. Zhaoqing Guangdong

Star Lake Bioscience Co., Inc. experienced a decline in stock price, contrasting with the broader market's performance. Over the past week, the stock has fallen significantly, although it shows positive returns over the month and year-to-date. The company maintains a solid market capitalization and attractive financial metrics.

Star Lake Bioscience Co., Inc. has shown strong stock performance, with a notable increase on March 11, 2026. The company has a market capitalization of CNY 5,262 million and a P/E ratio of 9.00. Its impressive growth includes a year-to-date rise of 16.98% and a five-year increase of 106.35%.

Star Lake Bioscience Co., Inc. has experienced notable stock activity, reaching an intraday high amid a modest rise in the China Shanghai Composite. The company has shown strong performance metrics, with significant annual returns and profit growth, while maintaining an attractive valuation and dividend yield in the FMCG sector.

Star Lake Bioscience Co., Inc. has experienced notable stock performance, achieving a significant intraday high while contrasting with a decline in the broader market. The company has shown strong gains over the past week and year-to-date, supported by solid financial metrics and a competitive dividend yield.